The Delhi High Court has requested the Centre to present its position regarding a petition filed by a pharmaceutical company that challenges the government’s decision to ban the manufacture, sale, and distribution of certain Fixed Dose Combination (FDC) drugs for human use.
FDC drugs are those that contain a fixed ratio of two or more active pharmaceutical ingredients (APIs).
While issuing notices on three petitions filed by Glenmark Pharmaceuticals Ltd against the ban, the court has directed that the FDC drugs produced by the petitioners, which are already in the distribution channel, should not be withdrawn. It further ordered that no coercive measures be taken against the petitioners.
The Supreme Court has upheld a decision by the Madras High Court granting a divorce…
The Delhi High Court has granted transit anticipatory bail to a lawyer whose brother is…
Former Supreme Court Justice Madan B Lokur has been recently named the chairperson of the…
The Karnataka High Court has recently directed the National Law School of India University (NLSIU)…
The Allahabad High Court has directed the Uttar Pradesh Vigilance Department to investigate the Himalayan…
The Allahabad High Court on Friday issued an order staying the arrest of Mohammed Zubair,…